These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 18524684

  • 1. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.
    Arnold LM, Russell IJ, Diri EW, Duan WR, Young JP, Sharma U, Martin SA, Barrett JA, Haig G.
    J Pain; 2008 Sep; 9(9):792-805. PubMed ID: 18524684
    [Abstract] [Full Text] [Related]

  • 2. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
    Pauer L, Winkelmann A, Arsenault P, Jespersen A, Whelan L, Atkinson G, Leon T, Zeiher B, A0081100 Investigators.
    J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636
    [Abstract] [Full Text] [Related]

  • 3. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.
    Mease PJ, Russell IJ, Arnold LM, Florian H, Young JP, Martin SA, Sharma U.
    J Rheumatol; 2008 Mar; 35(3):502-14. PubMed ID: 18278830
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE, Lee DI, Lee SC, Song SO, Yoon DM, Yoon MH, Kim HK, Lee YW, Kim C, Lee PB.
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y, Ding X, Cheng Y, Fan D, Tan L, Wang Y, Zhao Z, Hong Z, Zhou D, Pan X, Chen S, Martin A, Tang H, Cui L.
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [Abstract] [Full Text] [Related]

  • 6. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial.
    Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, Young JP, LaMoreaux LK, Martin SA, Sharma U, Pregabalin 1008-105 Study Group.
    Arthritis Rheum; 2005 Apr; 52(4):1264-73. PubMed ID: 15818684
    [Abstract] [Full Text] [Related]

  • 7. Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study.
    Roth T, Lankford DA, Bhadra P, Whalen E, Resnick EM.
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):597-606. PubMed ID: 22232085
    [Abstract] [Full Text] [Related]

  • 8. Long-term maintenance of response across multiple fibromyalgia symptom domains in a randomized withdrawal study of pregabalin.
    Pauer L, Atkinson G, Murphy TK, Petersel D, Zeiher B.
    Clin J Pain; 2012 Sep; 28(7):609-14. PubMed ID: 22688598
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Arnold LM, Hirsch I, Sanders P, Ellis A, Hughes B.
    Arthritis Rheum; 2012 Jul; 64(7):2387-97. PubMed ID: 22275142
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia.
    Ohta H, Oka H, Usui C, Ohkura M, Suzuki M, Nishioka K.
    Arthritis Res Ther; 2012 Oct 12; 14(5):R217. PubMed ID: 23062189
    [Abstract] [Full Text] [Related]

  • 11. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.
    Arthritis Rheum; 2004 Sep 12; 50(9):2974-84. PubMed ID: 15457467
    [Abstract] [Full Text] [Related]

  • 12. Correlations between fibromyalgia symptom and function domains and patient global impression of change: a pooled analysis of three randomized, placebo-controlled trials of pregabalin.
    Arnold LM, Zlateva G, Sadosky A, Emir B, Whalen E.
    Pain Med; 2011 Feb 12; 12(2):260-7. PubMed ID: 21266008
    [Abstract] [Full Text] [Related]

  • 13. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.
    Tölle T, Freynhagen R, Versavel M, Trostmann U, Young JP.
    Eur J Pain; 2008 Feb 12; 12(2):203-13. PubMed ID: 17631400
    [Abstract] [Full Text] [Related]

  • 14. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K, Pollack MH, Feltner DE, Lydiard RB, Zimbroff DL, Bielski RJ, Tobias K, Brock JD, Zornberg GL, Pande AC.
    Arch Gen Psychiatry; 2005 Sep 12; 62(9):1022-30. PubMed ID: 16143734
    [Abstract] [Full Text] [Related]

  • 15. Pregabalin: an alpha2-delta (alpha2-delta) ligand for the management of fibromyalgia.
    Arnold L, Mease P, Silverman S.
    Am J Manag Care; 2010 May 12; 16(5 Suppl):S138-43. PubMed ID: 20586522
    [Abstract] [Full Text] [Related]

  • 16. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief.
    Stacey BR, Barrett JA, Whalen E, Phillips KF, Rowbotham MC.
    J Pain; 2008 Nov 12; 9(11):1006-17. PubMed ID: 18640074
    [Abstract] [Full Text] [Related]

  • 17. Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia.
    Arnold LM, Emir B, Murphy TK, Zeiher BG, Pauer L, Scott G, Petersel D.
    Clin Ther; 2012 May 12; 34(5):1092-102. PubMed ID: 22503162
    [Abstract] [Full Text] [Related]

  • 18. Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia.
    Arnold LM, Leon T, Whalen E, Barrett J.
    Psychosomatics; 2010 May 12; 51(6):489-97. PubMed ID: 21051680
    [Abstract] [Full Text] [Related]

  • 19. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.
    Garcia-Borreguero D, Larrosa O, Williams AM, Albares J, Pascual M, Palacios JC, Fernandez C.
    Neurology; 2010 Jun 08; 74(23):1897-904. PubMed ID: 20427750
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.
    Arnold LM, Zhang S, Pangallo BA.
    Clin J Pain; 2012 Jun 08; 28(9):775-81. PubMed ID: 22971669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.